Could polymorphisms in ATP-binding cassette C3/multidrug resistance associated protein 3 (ABCC3/MRP3) modify colorectal cancer risk?

European Journal of Cancer

Volumn 44, Issue 6, 2008, Pages 854-857

  Campa, Daniele ^a,b   Vodicka, Pavel ^c   Pardini, Barbara ^c   Novotny, Jan ^d   Försti, Asta ^a   Hemminki, Kari ^a   Barale, Roberto ^b   Canzian, Federico ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF PISA   (Italy)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

ABCC3; Colorectal cancer; Polymorphisms; Susceptibility; Transporter

Indexed keywords

ABC TRANSPORTER; ARGININE; ATP BINDING CASSETTE TRANSPORTER C3; CYTOSINE; DNA; HISTIDINE; MULTIDRUG RESISTANCE PROTEIN 3; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NUCLEOTIDE BINDING SITE; PHARMACOGENETICS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 41849133140     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.02.004     Document Type: Article

References (17)

1. Hediger M.A., Romero M.F., Peng J.B., Rolfs A., Takanaga H., and Bruford E. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins introduction. Pflugers Arch 447 (2004) 465-468
2. Belinsky M.G., Bain L.J., Balsara B.B., Testa J.R., and Kruh G.D. Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins. J Natl Cancer Inst 90 (1998) 1735-1741
3. Kiuchi Y., Suzuki H., Hirohashi T., Tyson C.A., and Sugiyama Y. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). FEBS Lett 433 (1998) 149-152
4. Konig J., Rost D., Cui Y., and Keppler D. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29 (1999) 1156-1163
5. Akita H., Suzuki H., Hirohashi T., Takikawa H., and Sugiyama Y. Transport activity of human MRP3 expressed in Sf9 cells: comparative studies with rat MRP3. Pharm Res 19 (2002) 34-41
6. Hirohashi T., Suzuki H., and Sugiyama Y. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3(MRP3). J Biol Chem 274 (1999) 15181-15185
7. +-dependent bile-acid transporter. Biochem J 369 (2003) 23-30
8. Zelcer N., Saeki T., Reid G., Beijnen J.H., and Borst P. Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). J Biol Chem 276 (2001) 46400-46407
9. Zeng H., Liu G., Rea P.A., and Kruh G.D. Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res 60 (2000) 4779-4784
10. Zeng H., Bain L.J., Belinsky M.G., and Kruh G.D. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. Cancer Res 23 (1999) 5964-5967
11. Kool M., van der Linden M., de Haas M., et al. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci USA 96 (1999) 6914-6919
12. Scheffer G.L., Kool M., de Haas M., et al. Tissue distribution and induction of human multidrug resistant protein 3. Lab Invest 82 (2002) 193-201
13. Zimmermann C., Gutmann H., Hruz P., Gutzwiller J.P., Beglinger C., and Drewe J. Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tract. Drug Metab Dispos 33 (2005) 219-224
14. Lang T., Hitzl M., Burk O., et al. Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver. Pharmacogenetics 14 (2004) 155-164
15. Vodicka P., Stetina R., Polakova V., et al. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis 23 (2007) 657-664
16. Keitel V., Kartenbeck J., Nies A.T., Spring H., Brom M., and Keppler D. Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome. Hepatology 32 (2000) 1317-1328
17. Lee Y.M., Cui Y., Konig J., et al. Identification and functional characterization of the natural variant MRP3-Arg1297His of human multidrug resistance protein 3 (MRP3/ABCC3). Pharmacogenetics 14 (2004) 213-223